Lamin A + C (phospho Ser22) Cell Based ELISA Kit (A102514)

Lamin A + C (phospho Ser22) Cell Based ELISA Kit

Cell-based (qualitative)

This Lamin A + C (phospho Ser22) Cell Based ELISA Kit allows for the detection of Lamin A + C (phospho Ser22) and the effects that certain stimulation conditions have on Lamin A + C (phospho Ser22) expression in different cell lines. Qualitative determination of Lamin A + C (phospho Ser22) concentration is achieved by an indirect ELISA format. In essence, the Lamin A + C (phospho Ser22) is captured by Anti-Lamin A + C (phospho Ser22) Antibodies which in turn are detected by HRP-conjugated secondary antibodies. Through this binding, the HRP enzyme (conjugated to the secondary antibody) can catalyze a colorimetric reaction upon substrate addition. Due to the qualitative nature of this Lamin A + C (phospho Ser22) Cell Based ELISA Kit, multiple normalization methods are described: 1) Anti-GAPDH Antibody is included to serve as an internal positive control in normalizing the target absorbance values. 2) Following the colorimetric measurement of HRP activity via substrate addition, the Crystal Violet whole-cell staining method is used to determine cell density. After staining, the results can be analyzed by normalizing the absorbance values to cell amounts, by which the plating difference can be adjusted. 3) Anti-Lamin A + C Antibody is provided for normalization purposes. The absorbance values obtained for the non-phosphorylated target can be used to normalize the absorbance values for the phosphorylated target.

Microplate

Adherent cells and suspension cells.

> 5000 Cells

4 hours 30 minutes

Human, Mouse, Rat

Store at + 4°C. Stable for 6 months.

70 kDa lamin, Cardiomyopathy dilated 1A (autosomal dominant), CDCD1, CDDC, CMD1A, CMT2B1, EMD2, FPL, FPLD, FPLD2, HGPS, IDC, Lamin, Lamin A, Lamin A/C, Lamin A/C like 1, Lamin C, Lamin-A/C, LDP1, LFP, LGMD1B, Limb girdle muscular dystrophy 1B (autosomal dominant), LMN 1, LMN A, LMN C, LMN1, LMNA, LMNA_HUMAN, LMNC, LMNL1, Prelamin A/C, PRO1, Renal carcinoma antigen NY REN 32, Renal carcinoma antigen NY-REN-32, Renal carcinoma antigen NYREN32